TOPLINE: High-dose theta burst stimulation (TBS) is associated with significantly improved poststroke upper extremity (UE) motor function. Both intermittent TBS (iTBS) and continuous TBS (cTBS) groups […]

TOPLINE: Dupilumab remained effective in most patients with atopic dermatitis (AD) up to 5 years, although nearly a quarter of patients in the cohort study discontinued […]

TOPLINE: The maternal and neonatal outcomes in pregnant women treated with anti–interleukin (IL)-6 therapy for COVID-19 are largely favorable, with transient neonatal cytopenia observed in around […]

TOPLINE: In patients with skin or lung cancer, drugs that inhibit BRAF (v-raf murine sarcoma viral oncogene homolog B) mutations increase the risk for uveitis dramatically compared […]

TOPLINE: Uptake of infliximab biosimilars rose slowly across private insurance, Medicaid, and Medicare when two were available in the United States during 2016-2020 but increased significantly […]

TOPLINE: The monoclonal antibody ustekinumab, approved for treating psoriasis, psoriatic arthritis, and inflammatory bowel disease, appears to safely protect pancreatic beta-cell function in children with new-onset […]

TOPLINE: An easy-to-use web-based prognostic tool, MetroPancreas, may help predict the likelihood of futile pancreatectomy in patients with resectable pancreatic ductal adenocarcinoma and improve patient selection […]

TOPLINE: A systematic review and network meta-analysis found cranberry juice can help prevent urinary tract infections (UTIs). METHODOLOGY: With an increasing prevalence of antimicrobial resistance and […]

TOPLINE: Adding metastasis-directed therapy (MDT) to systemic therapy improves progression-free survival (PFS) to 10.3 months vs 2.5 months with systemic therapy alone. The study involved 41 […]